Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 6-month formulation in Central Precocious Puberty
NCT01467882Phase 3Completed
- Sponsor
- Debiopharm
- Start
- Apr 2012
- Primary completion
- Aug 2013
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Debiopharm. Started Apr 2012; status: completed.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT01467882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467882.